Trial · NCT07893444
BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children
NCT07893444, Phase 2, Recruiting, Huashan Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children. Trials, record NCT07893444. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07893444
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children
- NCT number
- NCT07893444
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 90 participants, estimated
- Lead sponsor
- Huashan Hospital
- Conditions
- Tuberculosis
- Interventions
- 4-month FDC-based regimen, 3-month BDCZ regimen, Standard 6-month treatment regimen
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Tuberculosis-free survival at 12 months | 12 months after treatment initiation | Proportion of participants alive and free of tuberculosis at 12 months after treatment initiation. |
| Primary | Incidence of grade 3 or higher adverse events | From treatment initiation to the end of the assigned treatment regimen (3, 4, or 6 months) | Proportion of participants experiencing one or more grade 3 or higher adverse events during treatment. |
| Secondary | Tuberculosis recurrence at 12 months | 12 months after treatment initiation | Proportion of participants who experience tuberculosis recurrence within 12 months after treatment initiation. |
| Secondary | Treatment success and treatment failure at the end of treatment | At the end of the assigned treatment regimen (3, 4, or 6 months) | Proportions of participants classified as having treatment success or treatment failure according to the protocol-defined physician assessment at the end of the assigned treatment regimen. |
| Secondary | Tuberculosis-free survival at 18 and 24 months | 18 and 24 months after treatment initiation | Proportion of participants alive and free of tuberculosis at 18 and 24 months after treatment initiation. |
| Secondary | Tuberculosis recurrence at 18 and 24 months | 18 and 24 months after treatment initiation | Proportion of participants who experience tuberculosis recurrence within 18 and 24 months after treatment initiation. |
| Secondary | Clinical outcomes at the end of follow-up | 24 months after treatment initiation | Proportions of participants with favorable and unfavorable clinical outcomes at the end of follow-up, as defined in the study protocol. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07893444
GET https://conductscience.org/api/trials/v1/NCT07893444/registered